A Phase 1 trial that is testing Modex's vaccine against the Epstein-Barr virus, a strong risk factor for MS, has dosed its ...

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

Human Metapneumovirus (HMPV) is raising concerns with its increasing infections in China and other regions. While the virus ...

Though designed to help the body fight infection and repair damage, inflammation can trigger serious illness when it becomes ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

If you have developed a virus that is causing an illness, it is natural to wonder if this can be transmitted to your ...

(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...